DOSAGE;DECREASED;CLEARANCE
DOSAGE;DECREASED;CONCENTRATIONS
DOSAGE;DECREASED;DOSE
DOSAGE;DECREASED;DOSE-ADJUSTED TROUGH CONCENTRATIONS
DOSAGE;DECREASED;LIKELIHOOD
DOSAGE;DECREASED;METABOLISM
DOSAGE;DECREASED;NAN
DOSAGE;DECREASED;RESPONSE
DOSAGE;DECREASED;RISK
DOSAGE;DECREASED;SEVERITY
DOSAGE;DECREASED;TROUGH CONCENTRATION
DOSAGE;INCREASED;CLEARANCE
DOSAGE;INCREASED;CONCENTRATIONS
DOSAGE;INCREASED;DOSE
DOSAGE;INCREASED;DOSE-ADJUSTED TROUGH CONCENTRATIONS
DOSAGE;INCREASED;EXPOSURE
DOSAGE;INCREASED;LIKELIHOOD
DOSAGE;INCREASED;METABOLISM
DOSAGE;INCREASED;NAN
DOSAGE;INCREASED;RESPONSE
DOSAGE;INCREASED;RISK
DOSAGE;INCREASED;SENSITIVITY
DOSAGE;INCREASED;SEVERITY
DOSAGE;INCREASED;TIME RESPONSE
DOSAGE;INCREASED;TROUGH CONCENTRATION
DOSAGE;NAN;NAN
DOSAGE;nan;DOSE
EFFICACY;DECREASED;ACTIVITY
EFFICACY;DECREASED;CATALYTIC ACTIVITY
EFFICACY;DECREASED;CLEARANCE
EFFICACY;DECREASED;CLINICAL BENEFIT
EFFICACY;DECREASED;CONCENTRATIONS
EFFICACY;DECREASED;DOSE
EFFICACY;DECREASED;DOSE-ADJUSTED TROUGH CONCENTRATIONS
EFFICACY;DECREASED;EXPOSURE
EFFICACY;DECREASED;INHIBITION
EFFICACY;DECREASED;LIKELIHOOD
EFFICACY;DECREASED;METABOLISM
EFFICACY;DECREASED;NAN
EFFICACY;DECREASED;RESISTANCE
EFFICACY;DECREASED;RESPONSE
EFFICACY;DECREASED;RISK
EFFICACY;DECREASED;SENSITIVITY
EFFICACY;DECREASED;SEVERITY
EFFICACY;DECREASED;TIME RESPONSE
EFFICACY;INCREASED;ACTIVITY
EFFICACY;INCREASED;CLEARANCE
EFFICACY;INCREASED;CLINICAL BENEFIT
EFFICACY;INCREASED;CONCENTRATIONS
EFFICACY;INCREASED;DISCONTINUATION
EFFICACY;INCREASED;DOSE
EFFICACY;INCREASED;ENZYME ACTIVITY
EFFICACY;INCREASED;EXPOSURE
EFFICACY;INCREASED;EXPRESSION
EFFICACY;INCREASED;LIKELIHOOD
EFFICACY;INCREASED;NAN
EFFICACY;INCREASED;RESISTANCE
EFFICACY;INCREASED;RESPONSE
EFFICACY;INCREASED;RISK
EFFICACY;INCREASED;SENSITIVITY
EFFICACY;INCREASED;SEVERITY
EFFICACY;INCREASED;TIME RESPONSE
EFFICACY;NAN;LIKELIHOOD
EFFICACY;NAN;NAN
EFFICACY;NAN;RISK
EFFICACY;NAN;SEVERITY
EFFICACY;nan;ACTIVITY
EFFICACY;nan;DOSE
EFFICACY;nan;EXPOSURE
EFFICACY;nan;PROTEIN STABILITY
EFFICACY;nan;RESISTANCE
EFFICACY;nan;RESPONSE
METABOLISM/PK;DECREASED;ACTIVITY
METABOLISM/PK;DECREASED;AFFINITY
METABOLISM/PK;DECREASED;CATALYTIC ACTIVITY
METABOLISM/PK;DECREASED;CLEARANCE
METABOLISM/PK;DECREASED;CLINICAL BENEFIT
METABOLISM/PK;DECREASED;CONCENTRATIONS
METABOLISM/PK;DECREASED;DOSE
METABOLISM/PK;DECREASED;DOSE-ADJUSTED TROUGH CONCENTRATIONS
METABOLISM/PK;DECREASED;ENZYME ACTIVITY
METABOLISM/PK;DECREASED;EXPOSURE
METABOLISM/PK;DECREASED;EXPRESSION
METABOLISM/PK;DECREASED;FORMATION
METABOLISM/PK;DECREASED;GLUCURONIDATION
METABOLISM/PK;DECREASED;HALF-LIFE TIME
METABOLISM/PK;DECREASED;INHIBITION
METABOLISM/PK;DECREASED;LIKELIHOOD
METABOLISM/PK;DECREASED;METABOLISM
METABOLISM/PK;DECREASED;NAN
METABOLISM/PK;DECREASED;RESPONSE
METABOLISM/PK;DECREASED;RISK
METABOLISM/PK;DECREASED;SENSITIVITY
METABOLISM/PK;DECREASED;SEVERITY
METABOLISM/PK;DECREASED;STEADY-STATE CONCENTRATION
METABOLISM/PK;DECREASED;STEADY-STATE LEVEL
METABOLISM/PK;DECREASED;SULFATION
METABOLISM/PK;DECREASED;TRANSCRIPTION
METABOLISM/PK;DECREASED;TRANSPORT
METABOLISM/PK;DECREASED;TROUGH CONCENTRATION
METABOLISM/PK;DECREASED;UPTAKE
METABOLISM/PK;DECREASED;nan
METABOLISM/PK;INCREASED;ACTIVITY
METABOLISM/PK;INCREASED;CATALYTIC ACTIVITY
METABOLISM/PK;INCREASED;CLEARANCE
METABOLISM/PK;INCREASED;CONCENTRATIONS
METABOLISM/PK;INCREASED;DISCONTINUATION
METABOLISM/PK;INCREASED;DOSE
METABOLISM/PK;INCREASED;DOSE-ADJUSTED TROUGH CONCENTRATIONS
METABOLISM/PK;INCREASED;ENZYME ACTIVITY
METABOLISM/PK;INCREASED;EXPOSURE
METABOLISM/PK;INCREASED;EXPRESSION
METABOLISM/PK;INCREASED;FORMATION
METABOLISM/PK;INCREASED;GLUCURONIDATION
METABOLISM/PK;INCREASED;HALF-LIFE TIME
METABOLISM/PK;INCREASED;INHIBITION
METABOLISM/PK;INCREASED;LIKELIHOOD
METABOLISM/PK;INCREASED;METABOLISM
METABOLISM/PK;INCREASED;NAN
METABOLISM/PK;INCREASED;RESPONSE
METABOLISM/PK;INCREASED;RISK
METABOLISM/PK;INCREASED;SENSITIVITY
METABOLISM/PK;INCREASED;SEVERITY
METABOLISM/PK;INCREASED;STEADY-STATE CONCENTRATION
METABOLISM/PK;INCREASED;STEADY-STATE LEVEL
METABOLISM/PK;INCREASED;SULFATION
METABOLISM/PK;INCREASED;TIME RESPONSE
METABOLISM/PK;INCREASED;TRANSCRIPTION
METABOLISM/PK;INCREASED;TROUGH CONCENTRATION
METABOLISM/PK;INCREASED;nan
METABOLISM/PK;NAN;NAN
METABOLISM/PK;nan;CLEARANCE
METABOLISM/PK;nan;CONCENTRATIONS
METABOLISM/PK;nan;DOSE
METABOLISM/PK;nan;DOSE-ADJUSTED TROUGH CONCENTRATIONS
METABOLISM/PK;nan;EXPOSURE
METABOLISM/PK;nan;METABOLISM
METABOLISM/PK;nan;RESPONSE
METABOLISM/PK;nan;TROUGH CONCENTRATION
NAN;DECREASED;NAN
NAN;DECREASED;RISK
NAN;DECREASED;SEVERITY
NAN;INCREASED;LIKELIHOOD
NAN;INCREASED;NAN
NAN;INCREASED;RISK
NAN;NAN;NAN
NAN;NAN;SEVERITY
OTHER;DECREASED;ACTIVITY
OTHER;DECREASED;AFFINITY
OTHER;DECREASED;CATALYTIC ACTIVITY
OTHER;DECREASED;CLEARANCE
OTHER;DECREASED;CONCENTRATIONS
OTHER;DECREASED;DOSE
OTHER;DECREASED;ENZYME ACTIVITY
OTHER;DECREASED;EXPRESSION
OTHER;DECREASED;FORMATION
OTHER;DECREASED;GLUCURONIDATION
OTHER;DECREASED;LIKELIHOOD
OTHER;DECREASED;METABOLISM
OTHER;DECREASED;NAN
OTHER;DECREASED;PROTEIN STABILITY
OTHER;DECREASED;RESPONSE
OTHER;DECREASED;RISK
OTHER;DECREASED;SENSITIVITY
OTHER;DECREASED;SEVERITY
OTHER;DECREASED;STEADY-STATE LEVEL
OTHER;DECREASED;TRANSCRIPTION
OTHER;DECREASED;TRANSPORT
OTHER;DECREASED;UPTAKE
OTHER;INCREASED;ACTIVITY
OTHER;INCREASED;CLEARANCE
OTHER;INCREASED;CONCENTRATIONS
OTHER;INCREASED;DISCONTINUATION
OTHER;INCREASED;EXPOSURE
OTHER;INCREASED;EXPRESSION
OTHER;INCREASED;LIKELIHOOD
OTHER;INCREASED;LUCIFERASE ACTIVITY
OTHER;INCREASED;METABOLISM
OTHER;INCREASED;NAN
OTHER;INCREASED;RESISTANCE
OTHER;INCREASED;RESPONSE
OTHER;INCREASED;RISK
OTHER;INCREASED;SENSITIVITY
OTHER;INCREASED;SEVERITY
OTHER;INCREASED;STEADY-STATE LEVEL
OTHER;INCREASED;TRANSCRIPTION
OTHER;INCREASED;TRANSPORT
OTHER;INCREASED;nan
OTHER;NAN;NAN
OTHER;NAN;RISK
OTHER;nan;ACTIVITY
OTHER;nan;GLUCURONIDATION
OTHER;nan;RESPONSE
OTHER;nan;SENSITIVITY
PD;DECREASED;ACTIVITY
PD;DECREASED;AFFINITY
PD;DECREASED;CATALYTIC ACTIVITY
PD;DECREASED;EXPRESSION
PD;DECREASED;LIKELIHOOD
PD;DECREASED;METABOLISM
PD;DECREASED;RESPONSE
PD;INCREASED;ACTIVITY
PD;INCREASED;AFFINITY
PD;INCREASED;CONCENTRATIONS
PD;INCREASED;EXPOSURE
PD;INCREASED;LIKELIHOOD
PD;INCREASED;RESPONSE
PD;INCREASED;RISK
PD;INCREASED;SENSITIVITY
TOXICITY;DECREASED;AGE AT ONSET
TOXICITY;DECREASED;CLEARANCE
TOXICITY;DECREASED;CONCENTRATIONS
TOXICITY;DECREASED;DISCONTINUATION
TOXICITY;DECREASED;DOSE
TOXICITY;DECREASED;EXPOSURE
TOXICITY;DECREASED;EXPRESSION
TOXICITY;DECREASED;LIKELIHOOD
TOXICITY;DECREASED;METABOLISM
TOXICITY;DECREASED;NAN
TOXICITY;DECREASED;RESPONSE
TOXICITY;DECREASED;RISK
TOXICITY;DECREASED;SENSITIVITY
TOXICITY;DECREASED;SEVERITY
TOXICITY;INCREASED;CLEARANCE
TOXICITY;INCREASED;CONCENTRATIONS
TOXICITY;INCREASED;DISCONTINUATION
TOXICITY;INCREASED;DOSE
TOXICITY;INCREASED;DOSE-ADJUSTED TROUGH CONCENTRATIONS
TOXICITY;INCREASED;EXPOSURE
TOXICITY;INCREASED;EXPRESSION
TOXICITY;INCREASED;LIKELIHOOD
TOXICITY;INCREASED;METABOLISM
TOXICITY;INCREASED;NAN
TOXICITY;INCREASED;RESPONSE
TOXICITY;INCREASED;RISK
TOXICITY;INCREASED;SENSITIVITY
TOXICITY;INCREASED;SEVERITY
TOXICITY;NAN;NAN
TOXICITY;NAN;RISK
TOXICITY;NAN;SEVERITY
TOXICITY;nan;METABOLISM
TOXICITY;nan;RESPONSE
nan;DECREASED;ACTIVITY
nan;DECREASED;DOSE
nan;DECREASED;ENZYME ACTIVITY
nan;DECREASED;EXPRESSION
nan;DECREASED;RESPONSE
nan;DECREASED;STEADY-STATE LEVEL
nan;DECREASED;TRANSCRIPTION
nan;INCREASED;ACTIVITY
nan;INCREASED;CATALYTIC ACTIVITY
nan;INCREASED;CLINICAL BENEFIT
nan;INCREASED;CONCENTRATIONS
nan;INCREASED;DOSE
nan;INCREASED;DOSE-ADJUSTED TROUGH CONCENTRATIONS
nan;INCREASED;ENZYME ACTIVITY
nan;INCREASED;EXPRESSION
nan;INCREASED;HALF-LIFE
nan;INCREASED;RESPONSE
nan;INCREASED;TRANSCRIPTION
